108
Participants
Start Date
February 29, 2012
Primary Completion Date
May 31, 2014
Study Completion Date
August 14, 2018
Filgrastim
All subjects will receive standard treatment with paclitaxel followed by carboplatin intravenously during 18 weeks. Filgrastim (Neupogen) will be given prophylactically on day 5. An additional dose will be given on day 6 in case of severe neutropenia during the course of the trial.
Paclitaxel
All subjects will receive standard treatment with paclitaxel followed by carboplatin intravenously during 18 weeks. Filgrastim (Neupogen) will be given prophylactically on day 5. An additional dose will be given on day 6 in case of severe neutropenia during the course of the trial.
Carboplatin
All subjects will receive standard treatment with paclitaxel followed by carboplatin intravenously during 18 weeks. Filgrastim (Neupogen) will be given prophylactically on day 5. An additional dose will be given on day 6 in case of severe neutropenia during the course of the trial.
St. Maarten Duffel, Duffel
UZ Antwerpen, Edegem
Imeldaziekenhuis, Bonheiden
AZ Klina, Brasschaat
UZ Leuven, Leuven
Centre Hospitalier Régional de la Citadelle, Liège
CHU Sart Tilman Liège, Liège
Cliniques et maternité St. Elizabeth, Namur
Cliniques universitaires UCL de Mont-Godinne, Yvoir
Grand Hôpital de Charleroi, Charleroi
Cliniques du Sud-Luxembourg, Arlon
Centre Hospitalier de l'Ardenne, Libramont
CHU Tivoli, La Louvière
AZ Damiaan, Ostend
AZ Groeninge, Kortrijk
Jan Yperman Ziekenhuis, Ieper
AZ Nikolaas, Sint-Niklaas
Belgian Gynaecological Oncology Group
OTHER